Company intelligence / Profile preview

Wuhan H.X.K Fine Chemicals

Wuhan, Hubei, China

Ownership: Private
Development stage: Other

Overview

Wuhan HXK Fine Chemical is a Chinese enterprise specializing in the research, development, and large-scale production of fine chemicals and pharmaceutical intermediates. The company provides a broad portfolio of Active Pharmaceutical Ingredients (APIs) and chemical building blocks used in the synthesis of small molecule drugs. Their core business includes custom synthesis and contract manufacturing services for global pharmaceutical and agrochemical clients. Operating out of Wuhan, they maintain facilities for high-purity chemical production and quality control to meet international standards.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Wuhan H.X.K Fine Chemicals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan H.X.K Fine Chemicals.

Explore the full profile